panflu Stats

[Mixin]

Aug 14, 2009 Federal officials today during a pandemic H1N1 planning update dialed back the number of novel flu vaccine doses they expect in October from 120 million to 45 million, listing several reasons for the smaller projection.

the latest expectation is 45 million doses by mid October, with manufacturers delivering 20 million doses per week after that.

vaccine makers have a limited number of fill-and-finish sites, which are just completing seasonal flu vaccine production, but that federal officials are looking for ways to maximize the current capacity.

one of the companies making seasonal flu vaccine is having problems finishing up production so that it can clear the decks to make novel flu vaccine, Robinson said. The delay has impacted vaccine timelines by 4 to 6 weeks

federal officials will be working with manufacturers over the next 2 weeks to see if the improved yields are also seen in commercial production.

Antiviral update: 84 million treatment courses are currently in federal and state stockpiles and that 3 million more doses are expected soon. He projected that a total of 100 million antiviral treatment courses will be available this fall, but he added that only a small amount will be available commercially.

During the comment part of the meeting, some of the NBSB board members and members of the public expressed concerns about the current lack of an IV or IM antiviral treatment, urging officials to strongly consider approving an EUA for peramivir

http://www.cidrap.umn.edu/cidrap/content/influenza/swineflu/news/aug1409vaccine.html
_________________
https://twitter.com/mixin1771